Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:37 PM
Ignite Modification Date:
2025-12-24 @ 6:37 PM
NCT ID:
NCT02910557
Eligibility Criteria:
Inclusion Criteria:
* Patient has provided written informed consent
* Patient is an adult (≥ 18 years of age at the time of informed consent) with a diagnosis of melanoma
* Patient enrolled within 1 month of receiving the first dose of IMLYGIC for the treatment of melanoma
Exclusion Criteria:
\- Patient has a prior history of being a subject in an interventional clinical trial for IMLYGIC
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT02910557
Study Brief:
Protocol Section:
NCT02910557